These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 1685823)
1. [Changes in cell-mediated immune reactions in Crohn's disease]. Ecker KW; Güremen A; Feifel G Z Gastroenterol; 1991 Oct; 29(10):529-32. PubMed ID: 1685823 [TBL] [Abstract][Full Text] [Related]
2. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity. Lyanga J; Davis P; Thomson AB West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844 [TBL] [Abstract][Full Text] [Related]
3. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862 [TBL] [Abstract][Full Text] [Related]
4. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398 [TBL] [Abstract][Full Text] [Related]
6. Studies of cell-mediated immunity in patients with Crohn's disease. Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Malchow H; Steinhardt HJ; Lorenz-Meyer H; Strohm WD; Rasmussen S; Sommer H; Jarnum S; Brandes JW; Leonhardt H; Ewe K Scand J Gastroenterol; 1990 Mar; 25(3):235-44. PubMed ID: 1969678 [TBL] [Abstract][Full Text] [Related]
8. Immune activation and nutritional status in adult Crohn's disease patients. Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281 [TBL] [Abstract][Full Text] [Related]
9. Current status of drug therapy for inflammatory bowel disease. Peppercorn MA Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866 [TBL] [Abstract][Full Text] [Related]
10. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G subclasses in Crohn's disease with and without bowel resection. Bures J; Tichý M; Horácek J; Král B; Sobotka L; Cervenka B; Zadák Z; Komárková O; Fixa B; Pidrman V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):139-47. PubMed ID: 8159910 [TBL] [Abstract][Full Text] [Related]
12. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis. MacDermott RP; Bragdon MJ; Thurmond RD Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444 [TBL] [Abstract][Full Text] [Related]
14. [The role of nutritional status on serum immunoglobulins, body weight and postoperative infectious-related complications in patients with Crohn's disease receiving perioperative parenteral nutrition]. Yao GX; Wang XR; Jiang ZM; Zhang SY; Ma EL; Ni AP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):181-4. PubMed ID: 12905799 [TBL] [Abstract][Full Text] [Related]
15. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Castiglione F; Pignata S; Morace F; Sarubbi A; Baratta MA; D'Agostino L; D'Arienzo A; Mazzacca G Ital J Gastroenterol; 1996 May; 28(4):199-204. PubMed ID: 8842834 [TBL] [Abstract][Full Text] [Related]
16. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
17. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status. Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195 [TBL] [Abstract][Full Text] [Related]
18. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590 [TBL] [Abstract][Full Text] [Related]
19. Therapeutical experiments in ulcerative colitis and Crohn's disease. Nagy G; Prónay G; Ujszászy L Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469 [TBL] [Abstract][Full Text] [Related]